Healon Articles
Ferring present OA drug results at AAOS
19 May 2009
Ferring drug better in knee OA than IA-saline
20 October 2008
Euflexxa "cost-effective" at extending QALYs
19 November 2007
Vismed enters US trial for dry eye syndrome
22 January 2007
Stock Commentary - New York week toJune 26, 2006
3 July 2006
Bioniche acquires products
29 May 2006
Savient to sell production to Ferring
4 April 2005
Savient's Nuflexxa cleared by FDA
13 December 2004
US sales decline hits Santen results
22 November 2004
US sales growth boosts Santen results
31 May 2004
Pfizer sells surgical ophalmics business for $450M
26 April 2004
OSI to acquire Cell Pathways for $32M
17 February 2003
Tokyo pharma stocks - week to November 19
21 November 2001
Chugai revenues increase 6.2%
13 November 2001
Stock Commentary - Tokyo
31 May 2001
Tokyo pharma stocks week to April 30
2 May 2001
Sanofi-Synthelabo regains rights to Hyalgan
10 October 2000
New indication for OrthoLogic's Hyalgan
27 January 2000
Chugai reports recent filings and R&D pipeline
2 August 1999
Zimmer launches Orthovisc in Europe
5 March 1999
Bioniche Grows Stronger On Back of Cystistat
18 November 1998
FDA Asks For More Data On Orthovisc
20 October 1998
Chugai Restructures For The 21st Century
28 August 1998
BTG's BioLon For Eye Surgery
22 July 1998
Sanofi's Hyalgan Launched In USA
3 September 1997
Pharmacia Sees Downturn In Last Independent Results
20 November 1995
UK Code Of Practice Amendments, New Report
25 September 1995
1994 Brings Israel's BTG Closer To Goals
3 July 1995
Bioniche Reflects On Its Product Performance
15 May 1995
Productivity Improvements Boost Pharmacia Earnings
20 March 1995
Bioniche Launch In Canada
27 February 1995
Pharmacia's Sales Decline But Profits Rise
21 November 1994
Merck Frosst Licenses BTG Clot Imaging Agent
12 September 1994
2.8 Bill Kroner Interim Profits For Pharmacia
5 September 1994
BIOTECH GENERAL LOSS DESPITE GOOD SALES GROWTH
22 November 1993
ANALYSTS SAY PROCORDIA SPLIT IS SOUND LOGIC
19 July 1993
OPELEAD LAUNCH
7 June 1993
EUROPE STOCK COMMENT
7 June 1993
PROCORDIA/KABI PHARMACIA PROFITS UP
22 March 1993
KABI PHARMACIA IS PROCORDIA CROWN JEWEL
18 January 1993
Showing 1-42 of 42 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
